• Nippon Shinyaku’s dispute with Capricor over the U.S. commercialization agreement for CAP-1002 (deramiocel) will move to arbitration.
• A New Jersey Superior Court dismissed Capricor’s request for a preliminary injunction.
• The court granted Nippon Shinyaku’s motion to compel arbitration.
• Capricor withdrew its injunction motion, withdrawing its opposition to arbitration.
• Capricor sued in New Jersey on May 8, 2026, seeking termination of the U.S. commercialization agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nippon Shinyaku Co. Ltd. published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.